¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀ忬±¸ÇÐȸ The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis : 2020-12-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÀ忬±¸ÇÐȸ The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis : 2020-12-18
±³À°ÀÏÀÚ : 2020-12-18
±³À°Àå¼Ò : º¤½ºÄÚ ÄÁº¥¼ÇȦ  
±³À°ÁÖÁ¦ : The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis      
ÁÖÃÖ±â°ü : ´ëÇÑÀ忬±¸ÇÐȸ
´ã´çÀÚ : ±èº¸¶÷ 
¿¬¶ôó : 02-957-6145  
À̸ÞÀÏ : thekasid2@gmail.com      
±³À°Á¾·ù : ³»°úÀÇ»çÇÐ, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ±âŸ,      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í AOCC Member Pre-Registration US$100/ On-site Registration US$120, Non-Member Pre-Registration US$120/ On-site Registration US$150, Trainee / Resident / Nurse / Pharmacist / Researcher / Exhibitor Pre-Registration US$70/ On-site Registration US$90      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 18ÀÏ Paradise Hotel Busan, Sicily Room 07:00~07:40 Evolving therapeutic goals in ulcerative colitis: Important role of 5-ASA  Silvio Danese(Humanitas Research Hospital Italy) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 08:30~08:50 Current national guidelines in Asian countries  Choon Jin Ooi(Duke-NUS Medical School Singapore) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 08:50~09:10 International guidelines in Asia: Are they feasible and necessary?  Katsuyoshi Matsuoka(Toho University Sakura Medical Center Japan) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 09:10~09:30 Lessons from ECCO for developing international guidelines  Simon Travis(University of Oxford United Kingdom) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 09:30~09:50 How to develop Asian guidelines for IBD?  ¹Úµ¿ÀÏ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 12¿ù 18ÀÏ 101-104/106-109 09:50~10:00 Discussion  All() 
È޽Ġ12¿ù 18ÀÏ  10:00~10:30   () 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 10:30~10:50 Choosing the right therapy after conventional treatment failure  ÃÖâȯ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 10:50~11:10 Controversies and solutions in non-responders to anti-TNF  Mark Silverberg(Mount Sinai Hospital Canada) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 11:10~11:30 De-escalation of therapy in patients with quiescent IBD  Taku Kobayashi(Kitasato University Kitasato Institute Hospital Japan) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 11:30~11:45 Abstract 1-Oral Presentation  Abstract() 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 11:45~12:00 Abstract 2-Oral Presentation  Abstract() 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 12:00~12:30 Tight control – evidence for optimizing treatment  Edward V. Loftus Jr.(Mayo Clinic USA) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 12:30~13:00 Choosing a IBD drug and getting the most out of it  Taku Kobayashi(Kitasato University Kitasato Institute Hospital Japan) 
È޽Ġ12¿ù 18ÀÏ  13:00~13:30   () 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 13:30~13:50 Big data research: IBD fact sheet in Korea  ÀÌ°­¹®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 13:50~14:10 Stem cell therapy: Translating dreams into clinical practice  Ryuichi Okamoto(Tokyo Medical and Dental University Japan) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 14:10~14:30 Environmental triggers: Which one should we consider first?  Miguel Regueiro(Cleveland Clinic USA) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 14:30~14:50 Prevention of IBD: Is it possible?  Mark Silverberg(Mount Sinai Hospital Canada) 
Åä·Ð 12¿ù 18ÀÏ 101-104/106-109 14:50~15:00 Discussion  All() 
È޽Ġ12¿ù 18ÀÏ  15:00~15:30   () 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 15:30~15:50 Unmet needs in IBD research and practice  ÁøÀ±ÅÂ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 15:50~16:10 Quality of care in IBD: A holistic approach  Edward V. Loftus Jr.(Mayo Clinic USA) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 16:10~16:30 Suggestions for collaboration between ECCO and AOCC  Laurent Peyrin-Biroulet(Nancy University Hospital France) 
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 16:30~16:50 Future perspectives for AOCC  Minhu Chen(The First Affiliated Hospital Sun Yat-sen University China) 
Åä·Ð 12¿ù 18ÀÏ 101-104/106-109 16:50~17:00 Discussion  All() 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀ忬±¸ÇÐȸ The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis : 2020-12-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦15Â÷ ´ëÇѽŰæ¿Ü°úÇÐȸ ¼­¿ï¡¤°æÀÎ(°­¿ø-Á¦ÁÖ)Áöȸ Ãß°èÇмú´ëȸ : 2020-12-19
´ÙÀ½±Û ´ëÇÑÀ忬±¸ÇÐȸ The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis : 2020-12-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21045 ¼­¿ï 2024³â Á¦23ȸ ´ëÇÑôÃ߽űâ¼úÇÐȸ Ãá°è Á¤±âÇмú´ëȸ : 2024-06-29 0 6 2024-06-18
21044 ¼­¿ï (¿Â¶óÀÎ)2024³â »ó¹Ý±â ÀÇ·áºÐÀï ¿¹¹æ ¿¬¼ö±³À° : 2024-06-29 0 9 2024-06-18
21043 ºÎ»ê 2024³â ºÎ¿ï°æ ½½°üÀý ¿¬±¸È¸ ÇÏ°è¿öÅ©¼¥ : 2024-06-29 0 9 2024-06-18
21042 ¼­¿ï ´ëÇѳú½Å°æÀçÈ°ÇÐȸ Á¦10Â÷ °æÁ÷Àü¹®±³À°°úÁ¤ : 2024-06-29 0 13 2024-06-18
21041 ¼­¿ï Çѱ¹¿©¼ºÁ¤½ÅÀÇÇÐȸ ³­¹Î/ÀÌÁֹΠÁ¤½Å°Ç°­ : 2024-06-29 0 7 2024-06-18
21040 °æ±â Á¦12ȸ ÀÎÁ¦ÀÇ´ë ÀÏ»ê¹éº´¿ø ½Å°æ¿Ü°ú ¿¬¼ö°­Á : 2024-06-29 0 4 2024-06-18
21039 ºÎ»ê 2024³â Á¦2ȸ ´ëÇѼҾƺñ´¢ÀÇÇÐȸ Transitional Urology Symposium : 2024-06-29 0 11 2024-06-18
21038 ¼­¿ï 2024³â ´ëÇѳëÀνŰæÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-29 0 15 2024-06-18
21037 ¼­¿ï Á¦6ȸ °í·Á´ëÇб³ ¾È¾Ïº´¿ø ½Å°æ¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-06-29 0 15 2024-06-18
21036 ¼­¿ï 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-06-29 0 11 2024-06-18
21035 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 3Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-28 0 5 2024-06-18
21034 ºÎ»ê Á¦11Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Ãá°èÁ¾ÇÕ½ÉÆ÷Áö¾ö 2ÀÏÂ÷ : 2024-06-28 0 6 2024-06-18
21033 Àü³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦298Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-28 0 20 2024-06-18
21032 ¼­¿ï 2024 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-06-28 0 9 2024-06-18
21031 ¼­¿ï (2ÀÏÂ÷)2024³â ´ëÇÑô¼öÇÐȸ 2nd ISCoS Regional Symposium : 2024-06-28 0 7 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷